Genetic deficiency of cyclooxygenase-2 attenuates abdominal aortic aneurysm formation in mice.

[1]  V. King,et al.  Selective Cyclooxygenase-2 Inhibition With Celecoxib Decreases Angiotensin II–Induced Abdominal Aortic Aneurysm Formation in Mice , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[2]  M. Linton,et al.  Transiently heightened angiotensin II has distinct effects on atherosclerosis and aneurysm formation in hyperlipidemic mice. , 2006, Atherosclerosis.

[3]  Heinz Bönisch,et al.  Comparison of in vitro and in vivo reference genes for internal standardization of real-time PCR data. , 2006, BioTechniques.

[4]  Raimund Erbel,et al.  Aortic dimensions and the risk of dissection , 2005, Heart.

[5]  Chunxiang Zhang,et al.  ANG II-induced neointimal growth is mediated via cPLA2- and PLD2-activated Akt in balloon-injured rat carotid artery. , 2005, American journal of physiology. Heart and circulatory physiology.

[6]  Makoto Murakami,et al.  Prostaglandin E synthase, a terminal enzyme for prostaglandin E2 biosynthesis. , 2005, Journal of biochemistry and molecular biology.

[7]  R. Ricci,et al.  Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase , 2005, Nature Medicine.

[8]  J. Morrow,et al.  Cyclooxygenase-2 promotes early atherosclerotic lesion formation in ApoE-deficient and C57BL/6 mice. , 2005, Journal of molecular and cellular cardiology.

[9]  F. Ruschitzka,et al.  Celecoxib Decreases Endothelial Tissue Factor Expression Through Inhibition of c-Jun Terminal NH2 Kinase Phosphorylation , 2005, Circulation.

[10]  U. Halfter,et al.  Angiotensin II stimulated transcription of cyclooxygenase II is regulated by a novel kinase cascade involving Pyk2, MEKK4 and annexin II , 2005, Molecular and Cellular Biochemistry.

[11]  D. Carey,et al.  Suppression of Experimental Aortic Aneurysms: Comparison of Inducible Nitric Oxide Synthase and Cyclooxygenase Inhibitors , 2005, Annals of vascular surgery.

[12]  E. Isselbacher.  Thoracic and Abdominal Aortic Aneurysms , 2005, Circulation.

[13]  K. Sunagawa,et al.  Bone Marrow–Derived Monocyte Chemoattractant Protein-1 Receptor CCR2 Is Critical in Angiotensin II–Induced Acceleration of Atherosclerosis and Aneurysm Formation in Hypercholesterolemic Mice , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[14]  G. FitzGerald.  Coxibs and cardiovascular disease. , 2004, The New England journal of medicine.

[15]  Eric J Topol,et al.  Failing the public health--rofecoxib, Merck, and the FDA. , 2004, The New England journal of medicine.

[16]  Jilly F. Evans,et al.  The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm , 2004, Nature Medicine.

[17]  K. Walsh,et al.  Celecoxib, a Cyclooxygenase-2 Inhibitor, Reduces Neointimal Hyperplasia Through Inhibition of Akt Signaling , 2004, Circulation.

[18]  Simon G. Thompson,et al.  Abdominal Aortic Aneurysm Expansion: Risk Factors and Time Intervals for Surveillance , 2004, Circulation.

[19]  Alan Daugherty,et al.  Mouse Models of Abdominal Aortic Aneurysms , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[20]  A. Daugherty,et al.  Aortic Dissection Precedes Formation of Aneurysms and Atherosclerosis in Angiotensin II-Infused, Apolipoprotein E-Deficient Mice , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[21]  J. Powell,et al.  Prostaglandin E2 receptors in abdominal aortic aneurysm and human aortic smooth muscle cells. , 2003, Journal of vascular surgery.

[22]  P. Carmeliet,et al.  Urokinase-Type Plasminogen Activator Plays a Critical Role in Angiotensin II–Induced Abdominal Aortic Aneurysm , 2003, Circulation research.

[23]  J. Rutledge,et al.  Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs. , 2002, Physiological genomics.

[24]  J. Morrow,et al.  Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II. , 2002, The Journal of clinical investigation.

[25]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[26]  Robert W. Thompson,et al.  Monocyte chemotactic activity in human abdominal aortic aneurysms: role of elastin degradation peptides and the 67-kD cell surface elastin receptor. , 2002, Journal of vascular surgery.

[27]  J D Humphrey,et al.  Pathogenesis of abdominal aortic aneurysms: a multidisciplinary research program supported by the National Heart, Lung, and Blood Institute. , 2001, Journal of vascular surgery.

[28]  G. FitzGerald,et al.  Genetic and pharmacological analysis of prostanoid receptor function. , 2001, The Journal of clinical investigation.

[29]  S. Morham,et al.  Postnatal development and progression of renal dysplasia in cyclooxygenase-2 null mice. , 2000, Kidney international.

[30]  A Daugherty,et al.  Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. , 2000, The Journal of clinical investigation.

[31]  K. Mahboubi,et al.  Cyclooxygenase-2 is required for tumor necrosis factor-alpha- and angiotensin II-mediated proliferation of vascular smooth muscle cells. , 2000, Circulation research.

[32]  A. Daugherty,et al.  Chronic Angiotensin II Infusion Promotes Atherogenesis in Low Density Lipoprotein Receptor −/− Mice , 1999, Annals of the New York Academy of Sciences.

[33]  J. Powell,et al.  Inhibition of prostaglandin E2 synthesis in abdominal aortic aneurysms: implications for smooth muscle cell viability, inflammatory processes, and the expansion of abdominal aortic aneurysms. , 1999, Circulation.

[34]  G. Sicard,et al.  Indomethacin inhibits expansion of experimental aortic aneurysms via inhibition of the cox2 isoform of cyclooxygenase. , 1999, Journal of vascular surgery.

[35]  Mark D. Huffman,et al.  Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. , 1998, The Journal of clinical investigation.

[36]  R. Thompson,et al.  Prostaglandin E2 synthesis and cyclooxygenase expression in abdominal aortic aneurysms. , 1997, Journal of vascular surgery.

[37]  R. Thompson,et al.  Indomethacin prevents elastase-induced abdominal aortic aneurysms in the rat. , 1996, The Journal of surgical research.

[38]  R. Langenbach,et al.  Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse , 1995, Cell.

[39]  R. Mecham,et al.  Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. , 1995, The Journal of clinical investigation.

[40]  J. Salmon,et al.  Further studies on the enzymatic conversion of prostaglandin endoperoxide into prostacyclin by porcine aorta microsomes. , 1978, Biochimica et biophysica acta.

[41]  R. Garavito,et al.  Cyclooxygenases: structural, cellular, and molecular biology. , 2000, Annual review of biochemistry.

[42]  J. Powell,et al.  Inhibition of Prostaglandin E 2 Synthesis in Abdominal Aortic Aneurysms Implications for Smooth Muscle Cell Viability , Inflammatory Processes , and the Expansion of Abdominal Aortic Aneurysms , 1999 .